Clinical Trial Update: Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing short versus long duration dual antiplatelet therapy in patients undergoing lower extremity endovascular revascularization has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Peripheral Arterial Disease, Endovascular Procedures | Phase 3 | Status: WITHDRAWN